174 related articles for article (PubMed ID: 36029326)
21. Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months.
Deng Y; Ma J; Zhao S; Yang M; Sun Y; Zhang Q
Transl Oncol; 2023 Feb; 28():101614. PubMed ID: 36584488
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma.
Suzuki Y; Yano T; Suehiro Y; Iwasaki H; Hidaka M; Otsuka M; Sunami K; Ikeda H; Sawamura M; Ito T; Iida H; Nagai H
Int J Hematol; 2020 Dec; 112(6):817-824. PubMed ID: 32886278
[TBL] [Abstract][Full Text] [Related]
23. Early Progressing Follicular Lymphoma.
Wallace D; Casulo C
Curr Oncol Rep; 2021 Nov; 23(12):149. PubMed ID: 34797453
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of Histologic Transformation and Prognosis for Follicular Lymphoma].
Zhao TJ; Xu D; Chai XF; Chen YF; Wang DM; Fu XR; Li ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1069-1076. PubMed ID: 37551479
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B surface antigen positivity is associated with progression of disease within 24 months in follicular lymphoma.
Cheng CL; Fang WQ; Lin YJ; Yuan CT; Ko BS; Tang JL; Tien HF
J Cancer Res Clin Oncol; 2022 May; 148(5):1211-1222. PubMed ID: 34228224
[TBL] [Abstract][Full Text] [Related]
26. Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.
Mir F; Mattiello F; Grigg A; Herold M; Hiddemann W; Marcus R; Seymour JF; Bolen CR; Knapp A; Nielsen T; Casulo C
Am J Hematol; 2020 Dec; 95(12):1503-1510. PubMed ID: 32815559
[TBL] [Abstract][Full Text] [Related]
27. Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months.
Rajamäki A; Sunela K; Prusila REI; Kuusisto MEL; Mercadal S; Selander T; Kuitunen H; Pollari M; Jantunen E; Nystrand I; Sancho JM; Sorigue M; Kuittinen O
Leuk Lymphoma; 2021 Jul; 62(7):1639-1647. PubMed ID: 33546574
[TBL] [Abstract][Full Text] [Related]
28. [The prognostic significance of POD24 in 106 cases with splenic marginal lymphoma with bone marrow invasion].
Lyu R; Yan YT; Yi SH; Wang TY; Deng SH; Liu W; Huang WY; An G; Sui WW; Zou DH; Qiu LG; Li ZJ
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):228-233. PubMed ID: 32311893
[No Abstract] [Full Text] [Related]
29. Prognostic ability of five clinical risk scores in follicular lymphoma: A single-center evaluation.
Mozas P; Rivero A; Rivas-Delgado A; Correa JG; Condom M; Nadeu F; Giné E; Delgado J; Villamor N; Campo E; Magnano L; López-Guillermo A
Hematol Oncol; 2021 Dec; 39(5):639-649. PubMed ID: 34494300
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies.
Gebauer N; Mengler B; Kopelke S; Frydrychowicz A; Fürschke A; Hackenbroch C; Bauer A; Riecke A; von Bubnoff N; Fetscher S; Witte HM
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1789-1801. PubMed ID: 34415426
[TBL] [Abstract][Full Text] [Related]
31. Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
Jurinovic V; Metzner B; Pfreundschuh M; Schmitz N; Wandt H; Keller U; Dreger P; Dreyling M; Hiddemann W; Unterhalt M; Hoster E; Weigert O
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1172-1179. PubMed ID: 29605716
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of histologic grade and Ki-67 proliferation index in follicular lymphoma.
Xue T; Yu BH; Yan WH; Jiang XN; Tian T; Zhou XY; Li XQ
Hematol Oncol; 2020 Dec; 38(5):665-672. PubMed ID: 32627854
[TBL] [Abstract][Full Text] [Related]
33. Relationship between the absolute lymphocyte count/absolute monocyte count ratio, soluble interleukin 2 receptor level, serum programmed cell death 1 level, and the prognosis of patients with diffuse large B-cell lymphoma.
Li C; Li W; Xu G; You M; Wu W; Kuang L
Ann Palliat Med; 2021 Oct; 10(10):10938-10945. PubMed ID: 34763456
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma.
Nozaki K; Sugahara H; Ueda S; Ishikawa J; Fuji S; Masaie H; Tada Y; Karasuno T; Iida M; Mitsui H; Kamae T; Saito N; Moriyama Y; Kawakami M; Kato R; Nakae Y; Kida T; Kosugi S; Nakagawa M; Uchida Y; Azenishi Y; Sakaniwa R; Kitamura T; Shibayama H
Leuk Lymphoma; 2020 Sep; 61(9):2113-2121. PubMed ID: 32366194
[TBL] [Abstract][Full Text] [Related]
35. Serum high-density lipoprotein cholesterol level has a significant prognostic impact on outcomes of follicular lymphoma patients.
Matsuo T; Tashiro H; Shirasaki R; Sumiyoshi R; Yamamoto T; Saito S; Matsumoto K; Ooi J; Shirafuji N
Medicine (Baltimore); 2022 Jul; 101(30):e29541. PubMed ID: 35905283
[TBL] [Abstract][Full Text] [Related]
36. Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies.
Kelly JL; Salles G; Goldman B; Fisher RI; Brice P; Press O; Casasnovas O; Maloney DG; Soubeyran P; Rimsza L; Haioun C; Xerri L; LeBlanc M; Tilly H; Friedberg JW
J Clin Oncol; 2015 May; 33(13):1482-90. PubMed ID: 25823738
[TBL] [Abstract][Full Text] [Related]
37. Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma.
Kumagai S; Tashima M; Fujikawa J; Iwasaki M; Iwamoto Y; Sueki Y; Fukunaga A; Yanagita S; Nishikori M; Takaori-Kondo A; Arima N
Int J Hematol; 2014 Jun; 99(6):737-42. PubMed ID: 24756873
[TBL] [Abstract][Full Text] [Related]
38. Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies.
Rodgers TD; Casulo C; Boissard F; Launonen A; Parreira J; Cartron G
Oncol Ther; 2021 Dec; 9(2):329-346. PubMed ID: 34319556
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP.
Umino K; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Hematology; 2017 Oct; 22(9):521-526. PubMed ID: 28413914
[TBL] [Abstract][Full Text] [Related]
40. Does early disease progression predict survival after first line-treatment of Waldenström macroglobulinemia?
Labreuche J; Assouan D; Durot E; Tomowiak C; Roos-Weil D; Toussaint E; Bijou F; Lemal R; Brion A; Laribi K; Ysebaert L; Duhamel A; Morel P;
Hematol Oncol; 2022 Aug; 40(3):400-408. PubMed ID: 35385885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
